4:54 PM
 | 
Aug 07, 2017
 |  BC Extra  |  Company News

Management tracks: Pfenex, Alvotech, uniQure

Biosimilars company Pfenex Inc. (NYSE-M:PFNX) named Evert Schimmelpennink CEO, president and secretary. He succeeds interim CEO Patrick Lucy, who will continue as CBO. Rasmus Rojkjaer was named CEO at biosimilar company Alvotech ehf (Reykjavik, Iceland), replacing Schimmelpennink who stepped down.

Gene therapy company uniQure N.V. (NASDAQ:QURE) announced several appointments including Scott McMillan as COO. He was SVP of quality and technical operations at AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). The company...

Read the full 341 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >